Corcept Therapeutics
CORT
CORT
389 hedge funds and large institutions have $2.67B invested in Corcept Therapeutics in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 119 increasing their positions, 157 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 94
58% less capital invested
Capital invested by funds: $6.41B → $2.67B (-$3.74B)
69% less call options, than puts
Call options by funds: $57.1M | Put options by funds: $187M
Holders
389
Holding in Top 10
6
Calls
$57.1M
Puts
$187M
Top Buyers
| 1 | +$59M | |
| 2 | +$57.7M | |
| 3 | +$31.8M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$21.1M |
| 5 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$19.8M |
Top Sellers
| 1 | -$51.4M | |
| 2 | -$48.6M | |
| 3 | -$43.8M | |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
-$39.6M |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
-$39.5M |
